Integrated Filing — IndAS



General information about company

Scrip Code 533333
NSE Symbol FCL
MSEI Symbol NOTLISTED
ISIN INE045J01034
Name of company FINEOTEX CHEMICAL LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 23-07-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 16-07-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Single segment
Description of single segment Textile specialty chemicals
Start date and time of board meeting 23-07-2026   15:50:00
End date and time of board meeting 23-07-2026   17:00:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not Applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026 01-04-2026
B Date of end of reporting period 30-06-2026 30-06-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 8,514.55 8,514.55
Other income 1,078.10 1,078.10
Total income 9,592.65 9,592.65
2 Expenses
(a) Cost of materials consumed 5,278.39 5,278.39
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (251.09) (251.09)
(d) Employee benefit expense 681.56 681.56
(e) Finance costs 19.26 19.26
(f) Depreciation, depletion and amortisation expense 218.19 218.19
(f) Other Expenses
1 Other Expenses 1,236.14 1,236.14
Total other expenses 1,236.14 1,236.14
Total expenses 7,182.45 7,182.45
3 Total profit before exceptional items and tax 2,410.20 2,410.20
4 Exceptional items 0.00 0.00
5 Total profit before tax 2,410.20 2,410.20
6 Tax expense
7 Current tax 415.00 415.00
8 Deferred tax (57.40) (57.40)
9 Total tax expenses 357.60 357.60
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 2,052.60 2,052.60
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 2,052.60 2,052.60
17 Other comprehensive income net of taxes 5.75 5.75
18 Total Comprehensive Income for the period 2,058.35 2,058.35
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 11,645.01 11,645.01
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.18 0.18
Diluted earnings (loss) per share from continuing operations 0.18 0.18
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.18 0.18
Diluted earnings (loss) per share from continuing and discontinued operations 0.18 0.18
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. The above results were reviewed and recommended by the Audit Committee and approved at the meeting of the Board of Directors of the Company held on 23rd July, 2026. The above results have been subjected to Limited Review by the Statutory Auditors of the Company. The Statutory Auditors have expressed an unqualified report on the above results. 2. This Statement is as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. 3. These financial results together with the results of previous period have been prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 Interim Financial Reporting prescribed under Section 133 of the companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India. 4. The figures of preceding quarter (i.e., three months ended March 31, 2026) are the balancing figures between the audited figure in respect of the full financial year and the published year to date figures upto the end of third quarter of the preceding financial year, which have been subject to limited review. 5. The Board of directors of the Company at their meeting held on Friday , 15th May , 2026 recommended a final divided of Rs. 0.05/- per equity share of face value of Rs. 1/- each, for the financial year ended 31st March, 2026. Final Dividend is Subject to approval of Shareholders. 6. The Company mainly operates in a single primary business segment of Speciality Chemicals, therefore disclosure requirements as per Ind AS 108, Operating Segments are not applicable to the Company. 7. Previous periods figure have been regrouped, rearranged, reclassified wherever necessary to correspond with those of the current period. 8. The Notes on the above results were approved at the meeting of the Board of Directors of the Company held on 23rd July, 2026. 9. The legal dispute concerning the Assignment Agreement for the property under 'Assets Held for Sale' had not been settled as of June 30, 2026. As of June 30, 2026, the company has paid Rs. 625.00 lakhs towards the settlement of the dispute. During Quarter 4 of the previous year, the company entered into a Memorandum of Understanding (MOU) with a third party for the transfer/assignment of the aforementioned Property Held for Sale. As of June 30, 2026, the company has received a total advance of Rs.1,008.00 lakhs ( Rs.800.00 lakhs in Q4 of the previous year and Rs.208.00 lakhs in the current quarter) As the transfer of the property had not been completed by 30 June 2026, the sale has not been recognised.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026 01-04-2026
Date of end of reporting period 30-06-2026 30-06-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026 01-04-2026
B Date of end of reporting period 30-06-2026 30-06-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss (5.75) (5.75)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 5.75 5.75